Pierre Kory, M.D., Associate Professor of Medicine at St. Luke's Aurora Medical Center, delivers passionate testimony during the Senate Homeland Security and Governmental Affairs Committee hearing on "Early Outpatient Treatment: An Essential Part of a COVID-19 Solution, Part II
In the last 9 months Dr. Kory and his colleagues have found mountains of data have emerged from around the world showing miraculous effectiveness of Ivermectin. It obliterates transmission of this virus. He says that there are large randomized controlled trials that show if you're taking Ivermectin you will not contract Covid-19. He thinks Ivermectin would be complimentary to vaccines and can be rapidly scaled and used immediately for those waiting for the vaccines to be distributed.
For treatment as little as one dose can be effective depending on the stage of the disease.
Bitchute link:
Here's a link to Dr. Kory's preprint manuscript:
Here's a summary of Dr. Kory's preprint and why the arguments against Ivermectin's use are faulty and made irrelevant with new data:
Here are some other studies I've found:
www.ncbi.nlm.nih.gov
In the last 9 months Dr. Kory and his colleagues have found mountains of data have emerged from around the world showing miraculous effectiveness of Ivermectin. It obliterates transmission of this virus. He says that there are large randomized controlled trials that show if you're taking Ivermectin you will not contract Covid-19. He thinks Ivermectin would be complimentary to vaccines and can be rapidly scaled and used immediately for those waiting for the vaccines to be distributed.
For treatment as little as one dose can be effective depending on the stage of the disease.
Bitchute link:
Here's a link to Dr. Kory's preprint manuscript:
Here's a summary of Dr. Kory's preprint and why the arguments against Ivermectin's use are faulty and made irrelevant with new data:
Why Isn’t Ivermectin Being Widely Researched and Utilized?
On November 13, a scientific review manuscript was posted to OSF, a medical pre-print server by Pierre Kory, MD, of the Front Line COVID-19 Critical Care Alliance (FLCCC). On November 3, TrialSite reported on the inclusion of the drug in the Alliance’s I-MASK+ protocol; the new manuscript...
trialsitenews.com
Here are some other studies I've found:
Ivermectin in COVID-19: What do we know?
www.ncbi.nlm.nih.gov
Last edited:
